Clinical Research Unit
Purpose of the CRU
The CRU is charged with facilitating the acquisition and administration of clinical trials research (under the direction of a Department of Neurology & Psychiatry faculty member in the role of Principal Investigator for the research).
This research is primarily targeted at the development and evaluation of investigational new drugs for pharmaceutical industry clients, with the goals of:» advancing scientific understanding of neurological and psychiatric conditions
» improving the prevention and treatment of such conditions, and
» expanding patient care options.
Types of conditions for which the CRU has conducted clinical trials include:
- » Alzheimer’s disease
- » Stroke
- » Myasthenia gravis
- » Amyotrophic lateral sclerosis
- » Multiple sclerosis
- » Epilepsy
- » Parkinson’s disease
- » Depression
- » Agitation
- » Chronic pediatric pain
Mission of the CRU
The CRU strives to deliver professional, courteous, and person-centered services to all those who participate in clinical trials research, under the umbrella of Good Clinical Practices, FDA-mandated procedures, and compliance with all ethical standards for research with people. ♦ We are located in Monteleone Hall on the Saint Louis University medical campus. Our facility includes a reception area, an examination area, nterview rooms, and confidential storage ares for research materials.
Academic Environment of the CRU
All CRU activities are conducted within a thriving academic medical environment that includes the Saint louis university School of Medicine, Saint Louis University Hospital and SSM Cardinal Glennon Children's Medical Center.
To contact the CRU, please call (314) 977-4900 for more information.